Thursday, February 18, 2021

Dental Amalgam Fillings: Recommendations About Their Use in Higher-Risk Groups

New graphics visualize recommendations about the use of dental amalgam fillings

If your email program has trouble displaying this email, view as a webpage.

US Food and Drug Administration

Recommendations About the Use of Dental Amalgam in Certain Higher-Risk Groups

Dental Amalgams Recommendations

The U.S. Food and Drug Administration (FDA) has developed graphics that provide a visualization of recommendations about the use of dental amalgam (a mercury-containing dental restorative or filling material) in certain groups of people who may be at greater risk for potential harmful health effects of mercury exposure. 

These higher-risk groups are:

  • Pregnant women and their developing fetuses
  • Women who are planning to become pregnant
  • Nursing women and their newborns and infants
  • Children, especially those younger than six
  • People with preexisting neurological disease
  • People with impaired kidney function
  • People with known heightened sensitivity (allergy) to mercury or other components of dental amalgam.

Get the Graphics

Questions?

If you have questions about COVID-19 testing options, contact the Division of Industry and Consumer Education.


This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

No comments:

Post a Comment